Prolonged hypolactatemia and increased total pyruvate dehydrogenase activity by dichloroacetate
- PMID: 7092922
- DOI: 10.1016/0006-2952(82)90019-3
Prolonged hypolactatemia and increased total pyruvate dehydrogenase activity by dichloroacetate
Abstract
Dichloroacetate (DCA) given gastrically as a single dose to healthy, fed rats caused transient lowering of blood glucose, lactate, and pyruvate. Chronic daily dosing caused lowering of these metabolites and a delay in the return of lactate to basal levels for 48 hr after the final dose. DCA caused activation of the pyruvate dehydrogenase complex (PDHC), with acute multiple dosing or chronic daily dosing. The elevated active PDHC persisted for 12 hr following the final dose. In addition, total PDHC activity was increased with chronic dosing and persisted for 48 hr following the final dose. This increase was not blocked by protein synthesis inhibitors. DCA increased isolated hepatocyte [14C-1]pyruvate oxidation and activated hepatocyte PDHC. Glyoxylate and oxalate, hepatic metabolites of DCA, were inhibitory at similar concentrations.
Similar articles
-
Dichloroacetate tissue concentrations and its relationship to hypolactatemia and pyruvate dehydrogenase activation.Biochem Pharmacol. 1982 Oct 1;31(19):3124-6. doi: 10.1016/0006-2952(82)90092-2. Biochem Pharmacol. 1982. PMID: 7150337
-
Effects of dichloroacetate on pyruvate metabolism in rat brain in vivo.Pediatr Res. 1984 Oct;18(10):936-8. doi: 10.1203/00006450-198410000-00005. Pediatr Res. 1984. PMID: 6493852
-
Effects of dichloroacetate on brain tissue pyruvate dehydrogenase.J Neurochem. 1983 Oct;41(4):1052-6. doi: 10.1111/j.1471-4159.1983.tb09050.x. J Neurochem. 1983. PMID: 6619845
-
Effects of various doses of sodium dichloroacetate on hyperlactatemia in fed ischemic rats.Ann Emerg Med. 1989 Nov;18(11):1162-71. doi: 10.1016/s0196-0644(89)80053-8. Ann Emerg Med. 1989. PMID: 2683899 Review.
-
The metabolic effects of dichloroacetate.Metabolism. 1981 Oct;30(10):1024-39. doi: 10.1016/0026-0495(81)90105-0. Metabolism. 1981. PMID: 7024720 Review. No abstract available.
Cited by
-
A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate.Mol Genet Metab. 2008 Apr;93(4):381-7. doi: 10.1016/j.ymgme.2007.10.131. Epub 2008 Feb 21. Mol Genet Metab. 2008. PMID: 18206410 Free PMC article.
-
Pharmacogenetic considerations with dichloroacetate dosing.Pharmacogenomics. 2016 May;17(7):743-53. doi: 10.2217/pgs-2015-0012. Epub 2016 May 4. Pharmacogenomics. 2016. PMID: 27143230 Free PMC article. Review.
-
Lactic Acidosis Related to Pharmacotherapy and Human Diseases.Pharmaceuticals (Basel). 2022 Nov 30;15(12):1496. doi: 10.3390/ph15121496. Pharmaceuticals (Basel). 2022. PMID: 36558947 Free PMC article. Review.
-
Role of dichloroacetate in the treatment of genetic mitochondrial diseases.Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1478-87. doi: 10.1016/j.addr.2008.02.014. Epub 2008 Jul 4. Adv Drug Deliv Rev. 2008. PMID: 18647626 Free PMC article. Review.
-
Targeting Cancer Metabolism - Revisiting the Warburg Effects.Toxicol Res. 2016 Jul;32(3):177-93. doi: 10.5487/TR.2016.32.3.177. Epub 2016 Jul 30. Toxicol Res. 2016. PMID: 27437085 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical